Theriva Biologics, Inc. (TOVX)
0.144
0.00 (0.00%)
USD |
NYAM |
Nov 18, 16:00
0.1421
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics Price to Book Value : 0.6146 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 0.6146 |
| November 17, 2026 | 0.5975 |
| November 16, 2026 | 0.5975 |
| November 13, 2026 | 0.615 |
| November 12, 2026 | 0.6829 |
| November 11, 2026 | 0.6867 |
| November 10, 2026 | 0.6581 |
| November 09, 2026 | 0.7076 |
| November 06, 2026 | 0.7106 |
| November 05, 2026 | 0.7187 |
| November 04, 2026 | 0.8109 |
| November 03, 2026 | 0.7768 |
| November 02, 2026 | 0.7853 |
| October 30, 2026 | 0.7277 |
| October 29, 2026 | 0.7981 |
| October 28, 2026 | 0.8105 |
| October 27, 2026 | 0.8024 |
| October 26, 2026 | 0.8254 |
| October 23, 2026 | 0.8365 |
| October 22, 2026 | 0.8109 |
| October 21, 2026 | 0.8391 |
| October 20, 2026 | 0.8877 |
| October 19, 2026 | 0.8736 |
| October 16, 2026 | 0.8873 |
| October 15, 2026 | 0.9048 |
| Date | Value |
|---|---|
| October 14, 2026 | 0.8958 |
| October 13, 2026 | 0.9206 |
| October 12, 2026 | 0.9364 |
| October 09, 2026 | 0.9261 |
| October 08, 2026 | 0.9692 |
| October 07, 2026 | 0.9987 |
| October 06, 2026 | 0.9475 |
| October 05, 2026 | 0.9603 |
| October 02, 2026 | 0.9607 |
| October 01, 2026 | 0.9603 |
| September 30, 2026 | 0.9603 |
| September 29, 2026 | 0.7908 |
| September 28, 2026 | 0.8153 |
| September 25, 2026 | 0.8307 |
| September 24, 2026 | 0.868 |
| September 23, 2026 | 0.8838 |
| September 22, 2026 | 0.8691 |
| September 21, 2026 | 0.8691 |
| September 18, 2026 | 0.8793 |
| September 17, 2026 | 0.9113 |
| September 16, 2026 | 0.8511 |
| September 15, 2026 | 0.8477 |
| September 14, 2026 | 0.8872 |
| September 11, 2026 | 0.9324 |
| September 10, 2026 | 0.914 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.220 |
| Alnylam Pharmaceuticals, Inc. | 5.550 |
| Anika Therapeutics, Inc. | 1.326 |
| Savara, Inc. | 8.995 |
| Arrowhead Pharmaceuticals, Inc. | 121.06 |
Price to Book Value Related Metrics
| PS Ratio | 20.23 |
| Price | 0.144 |
| Earnings Yield | -173.7% |
| Market Cap | 6.608M |